Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

Table 1 (abstract P225). See text for description

Analysis¹	Mean difference after vs. before MMR booster	95% CI
Active joint count	-0.25	-0.47 – -0.04*
Physician global assessment	-0.17	-0.32 – -0.01*
VAS well-being	-0.19	-0.57 – 0.20
clinical JADAS score	-0.58	-1.14 – -0.03*

¹adjusted for JIA disease duration, drug therapy (time-varying variables), age at JIA onset and JIA subtype (constant variables)
*statistically significant

ISSN: 1546-0096